Health
STAT+: Bladder cancer immunotherapy from CG Oncology reduced risk of tumor recurrence
Adam Feuerstein·STAT News·November 16, 2026

CG Oncology's bladder cancer immunotherapy reduced risk of tumor recurrence by 68% — results that may change how physicians treat certain patients.
Read the full story at STAT News →